Literature DB >> 20599223

Treatment with histone deacetylase inhibitor attenuates MAP kinase mediated liver injury in a lethal model of septic shock.

Robert A Finkelstein1, Yongqing Li, Baoling Liu, Fahad Shuja, Eugene Fukudome, George C Velmahos, Marc deMoya, Hasan B Alam.   

Abstract

BACKGROUND: Despite global efforts to improve the treatment of sepsis, it remains a leading cause of morbidity and mortality in intensive care units. We have previously shown that suberoylanilide hydroxamic acid (SAHA), a histone deacetylase inhibitor, markedly improves survival in a murine model of lipopolysaccharide (LPS)-induced shock. SAHA has anti-inflammatory properties that have not been fully characterized. The liver plays an important role in the production of acute phase reactants involved in the inflammatory cascade and is also one of the major organs that can become dysfunctional in septic shock. The purpose of this study was to assess the effect of SAHA treatment on MAP kinases and associated inflammatory markers in murine liver after LPS-induced injury.
METHODS: C57B1/6J mice were randomly divided into three groups: (A) experimental-given intraperitoneal (i.p.) SAHA (50 mg/kg) in dimethyl sulfoxide (DMSO) vehicle solution (n = 12); (B) control- given vehicle only (n = 12), and; (C) sham-given no treatment (n = 7). Two hours later, experimental and control mice were injected with LPS (20 mg/kg, i.p.) and experimental mice received a second dose of SAHA. Livers were harvested at 3, 24, and 48 h for analysis of inflammatory markers using Western Blot, Polymerase Chain Reaction (PCR), and Enzyme-Linked Immunosorbent Assay (ELISA) techniques.
RESULTS: After 3 h, the livers of animals treated with SAHA showed significantly (P < 0.05) decreased expression of the pro-inflammatory MAP kinases phosphorylated p38, phosphorylated ERK, myeloperoxidase and interleukin-6, and increased levels of the anti-inflammatory interleukin-10 compared with controls. Phospho-p38 expression remained low in the SAHA treated groups at 24 and 48 h.
CONCLUSION: Administration of SAHA is associated with attenuation of MAPK activation and alteration of inflammatory and anti-inflammatory markers in murine liver after a lethal LPS insult. The suppression of MAPK activity is rapid (within 3 h), and is sustained for up to 48 h post-treatment. These results may in part account for the improvement in survival shown in this model. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599223      PMCID: PMC4894321          DOI: 10.1016/j.jss.2010.04.024

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  57 in total

Review 1.  Chromatin remodeling and transcriptional activation: the cast (in order of appearance).

Authors:  F D Urnov; A P Wolffe
Journal:  Oncogene       Date:  2001-05-28       Impact factor: 9.867

Review 2.  MAP kinase p38 inhibitors: clinical results and an intimate look at their interactions with p38alpha protein.

Authors:  Matthew R Lee; Celia Dominguez
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

3.  Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition.

Authors:  Yongqing Li; Zengqiang Yuan; Baoling Liu; Elizabeth A Sailhamer; Christian Shults; George C Velmahos; Marc Demoya; Hasan B Alam
Journal:  J Trauma       Date:  2008-04

4.  Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding.

Authors:  Varsha Thakur; Michele T Pritchard; Megan R McMullen; Laura E Nagy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-01-12       Impact factor: 4.052

Review 5.  Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature.

Authors:  Emanuel P Rivers; Victor Coba; Melissa Whitmill
Journal:  Curr Opin Anaesthesiol       Date:  2008-04       Impact factor: 2.706

6.  Interleukin-10 impairs host defense in murine pneumococcal pneumonia.

Authors:  T van der Poll; A Marchant; C V Keogh; M Goldman; S F Lowry
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

7.  Involvement of tumor necrosis factor alpha, rather than interleukin-1alpha/beta or nitric oxides in the heme oxygenase-1 gene expression by lipopolysaccharide in the mouse liver.

Authors:  Takiko Oguro; Yuko Takahashi; Takashi Ashino; Atsushi Takaki; Seiji Shioda; Reiko Horai; Masahide Asano; Kenji Sekikawa; Yoichiro Iwakura; Takemi Yoshida
Journal:  FEBS Lett       Date:  2002-04-10       Impact factor: 4.124

8.  Valproic acid prevents hemorrhage-associated lethality and affects the acetylation pattern of cardiac histones.

Authors:  Earl Gonzales; Huazhen Chen; Richard Munuve; Tina Mehrani; Joy Britten-Webb; Amal Nadel; Hasan B Alam; David Wherry; David Burris; Elena Koustova
Journal:  Shock       Date:  2006-04       Impact factor: 3.454

9.  Surviving blood loss without fluid resuscitation.

Authors:  Christian Shults; Elizabeth A Sailhamer; Yongqing Li; Baoling Liu; Malek Tabbara; Muhammad Umar Butt; Fahad Shuja; Marc Demoya; George Velmahos; Hasan B Alam
Journal:  J Trauma       Date:  2008-03

10.  Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells.

Authors:  M Allen; L Svensson; M Roach; J Hambor; J McNeish; C A Gabel
Journal:  J Exp Med       Date:  2000-03-06       Impact factor: 14.307

View more
  18 in total

1.  Compound 9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury in mice by suppressing MAPK signalling.

Authors:  So-Jin Kim; Ki Seon Baek; Hyun-Ju Park; Young Hoon Jung; Sun-Mee Lee
Journal:  Br J Pharmacol       Date:  2016-02-22       Impact factor: 8.739

2.  Novel pharmacologic treatment attenuates septic shock and improves long-term survival.

Authors:  Ting Zhao; Yongqing Li; Baoling Liu; Zhengcai Liu; Wei Chong; Xiuzhen Duan; Danielle K Deperalta; George C Velmahos; Hasan B Alam
Journal:  Surgery       Date:  2013-08       Impact factor: 3.982

3.  Valproic acid alleviates memory deficits and attenuates amyloid-β deposition in transgenic mouse model of Alzheimer's disease.

Authors:  Ai-Guo Xuan; Xue-Bing Pan; Peng Wei; Wei-Dong Ji; Wen-Juan Zhang; Ji-Hong Liu; Le-Peng Hong; Wen-Liang Chen; Da-Hong Long
Journal:  Mol Neurobiol       Date:  2014-05-23       Impact factor: 5.590

4.  Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model.

Authors:  Ashley R Kochanek; Eugene Y Fukudome; Yongqing Li; Eleanor J Smith; Baoling Liu; George C Velmahos; Marc deMoya; David King; Hasan B Alam
Journal:  J Surg Res       Date:  2011-07-05       Impact factor: 2.192

Review 5.  Neutrophil extracellular traps, damage-associated molecular patterns, and cell death during sepsis.

Authors:  Toshiaki Iba; Miwa Murai; Isao Nagaoka; Yoko Tabe
Journal:  Acute Med Surg       Date:  2013-11-15

6.  Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model.

Authors:  Yongqing Li; Ting Zhao; Baoling Liu; Ihab Halaweish; Ralph Mazitschek; Xiuzhen Duan; Hasan B Alam
Journal:  J Trauma Acute Care Surg       Date:  2015-02       Impact factor: 3.313

7.  Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.

Authors:  Basar Cenik; Chantelle F Sephton; Colleen M Dewey; Xunde Xian; Shuguang Wei; Kimberley Yu; Wenze Niu; Giovanni Coppola; Sarah E Coughlin; Suzee E Lee; Daniel R Dries; Sandra Almeida; Daniel H Geschwind; Fen-Biao Gao; Bruce L Miller; Robert V Farese; Bruce A Posner; Gang Yu; Joachim Herz
Journal:  J Biol Chem       Date:  2011-03-23       Impact factor: 5.157

Review 8.  Histone Deacetylase Inhibitors: A Novel Strategy in Trauma and Sepsis.

Authors:  Aaron M Williams; Isabel S Dennahy; Umar F Bhatti; Ben E Biesterveld; Nathan J Graham; Yongqing Li; Hasan B Alam
Journal:  Shock       Date:  2019-09       Impact factor: 3.454

9.  Histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates Toll-like receptor 4 signaling in lipopolysaccharide-stimulated mouse macrophages.

Authors:  Wei Chong; Yongqing Li; Baoling Liu; Ting Zhao; Eugene Y Fukudome; Zhengcai Liu; William M Smith; George C Velmahos; Marc A deMoya; Hasan B Alam
Journal:  J Surg Res       Date:  2012-07-26       Impact factor: 2.192

10.  HDAC inhibitors in experimental liver and kidney fibrosis.

Authors:  Katrien Van Beneden; Inge Mannaerts; Marina Pauwels; Christiane Van den Branden; Leo A van Grunsven
Journal:  Fibrogenesis Tissue Repair       Date:  2013-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.